336 related articles for article (PubMed ID: 32351154)
1. Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death.
Schrage B; Geelhoed B; Niiranen TJ; Gianfagna F; Vishram-Nielsen JKK; Costanzo S; Söderberg S; Ojeda FM; Vartiainen E; Donati MB; Magnussen C; Di Castelnuovo A; Camen S; Kontto J; Koenig W; Blankenberg S; de Gaetano G; Linneberg A; Jørgensen T; Zeller T; Kuulasmaa K; Tunstall-Pedoe H; Hughes M; Iacoviello L; Salomaa V; Schnabel RB
J Am Heart Assoc; 2020 May; 9(9):e015218. PubMed ID: 32351154
[TBL] [Abstract][Full Text] [Related]
2. Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts: the BiomarCaRE project.
Rehm M; Rothenbacher D; Iacoviello L; Costanzo S; Tunstall-Pedoe H; Fitton CA; Söderberg S; Hultdin J; Salomaa V; Jousilahti P; Palosaari T; Kuulasmaa K; Waldeyer C; Schnabel RB; Zeller T; Blankenberg S; Koenig W;
ESC Heart Fail; 2022 Feb; 9(1):57-65. PubMed ID: 34825788
[TBL] [Abstract][Full Text] [Related]
3. NT-proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials.
Werhahn SM; Becker C; Mende M; Haarmann H; Nolte K; Laufs U; Zeynalova S; Löffler M; Dagres N; Husser D; Dörr M; Gross S; Felix SB; Petersmann A; Herrmann-Lingen C; Binder L; Scherer M; Hasenfuß G; Pieske B; Edelmann F; Wachter R
ESC Heart Fail; 2022 Feb; 9(1):100-109. PubMed ID: 34850596
[TBL] [Abstract][Full Text] [Related]
4. Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation.
Pandey A; Kim S; Moore C; Thomas L; Gersh B; Allen LA; Kowey PR; Mahaffey KW; Hylek E; Peterson ED; Piccini JP; Fonarow GC;
JACC Heart Fail; 2017 Jan; 5(1):44-52. PubMed ID: 28034376
[TBL] [Abstract][Full Text] [Related]
5. Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation.
Chatterjee NA; Chae CU; Kim E; Moorthy MV; Conen D; Sandhu RK; Cook NR; Lee IM; Albert CM
JACC Heart Fail; 2017 Aug; 5(8):552-560. PubMed ID: 28624486
[TBL] [Abstract][Full Text] [Related]
6. Relationship of diabetes, heart failure, and N-terminal pro-B-type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation.
Hofer F; Pailer U; Sulzgruber P; Gerges C; Winter MP; Giugliano RP; Gottsauner-Wolf M; Hülsmann M; Kazem N; Koller L; Schönbauer R; Niessner A; Hengstenberg C; Zelniker TA
ESC Heart Fail; 2022 Aug; 9(4):2367-2377. PubMed ID: 35593128
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.
Vermond RA; Geelhoed B; Verweij N; Tieleman RG; Van der Harst P; Hillege HL; Van Gilst WH; Van Gelder IC; Rienstra M
J Am Coll Cardiol; 2015 Sep; 66(9):1000-7. PubMed ID: 26314526
[TBL] [Abstract][Full Text] [Related]
8. Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death.
Brady PF; Chua W; Nehaj F; Connolly DL; Khashaba A; Purmah YJV; Ul-Qamar MJ; Thomas MR; Varma C; Schnabel RB; Zeller T; Fabritz L; Kirchhof PF
J Am Heart Assoc; 2022 Feb; 11(4):e022833. PubMed ID: 35112889
[TBL] [Abstract][Full Text] [Related]
9. Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium.
Magnussen C; Niiranen TJ; Ojeda FM; Gianfagna F; Blankenberg S; Vartiainen E; Sans S; Pasterkamp G; Hughes M; Costanzo S; Donati MB; Jousilahti P; Linneberg A; Palosaari T; de Gaetano G; Bobak M; den Ruijter HM; Jørgensen T; Söderberg S; Kuulasmaa K; Zeller T; Iacoviello L; Salomaa V; Schnabel RB;
JACC Heart Fail; 2019 Mar; 7(3):204-213. PubMed ID: 30819375
[TBL] [Abstract][Full Text] [Related]
10. Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).
Magnussen C; Niiranen TJ; Ojeda FM; Gianfagna F; Blankenberg S; Njølstad I; Vartiainen E; Sans S; Pasterkamp G; Hughes M; Costanzo S; Donati MB; Jousilahti P; Linneberg A; Palosaari T; de Gaetano G; Bobak M; den Ruijter HM; Mathiesen E; Jørgensen T; Söderberg S; Kuulasmaa K; Zeller T; Iacoviello L; Salomaa V; Schnabel RB;
Circulation; 2017 Oct; 136(17):1588-1597. PubMed ID: 29038167
[TBL] [Abstract][Full Text] [Related]
11. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment for incident heart failure in individuals with atrial fibrillation.
Schnabel RB; Rienstra M; Sullivan LM; Sun JX; Moser CB; Levy D; Pencina MJ; Fontes JD; Magnani JW; McManus DD; Lubitz SA; Tadros TM; Wang TJ; Ellinor PT; Vasan RS; Benjamin EJ
Eur J Heart Fail; 2013 Aug; 15(8):843-9. PubMed ID: 23594831
[TBL] [Abstract][Full Text] [Related]
13. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
Kristensen SL; Mogensen UM; Jhund PS; Rørth R; Anand IS; Carson PE; Desai AS; Pitt B; Pfeffer MA; Solomon SD; Zile MR; Køber L; McMurray JJV
Circ Heart Fail; 2019 Mar; 12(3):e005766. PubMed ID: 30871349
[TBL] [Abstract][Full Text] [Related]
14. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Incidence of Atrial Fibrillation in Ambulatory Patients With Heart Failure.
Pellicori P; Urbinati A; Kaur K; Zhang J; Shah P; Kazmi S; Capucci A; Cleland JGF; Clark AL
Am J Cardiol; 2019 Nov; 124(10):1554-1560. PubMed ID: 31558271
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
17. Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure.
Tan ESJ; Chan SP; Liew OW; Chong JPC; Leong GKT; Yeo DPS; Ong HY; Jaufeerally F; Yap J; Sim D; Ng TP; Ling LH; Lam CSP; Richards AM
Clin Chem; 2021 Jan; 67(1):216-226. PubMed ID: 33279970
[TBL] [Abstract][Full Text] [Related]
18. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
[TBL] [Abstract][Full Text] [Related]
20. Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort.
Geelhoed B; Börschel CS; Niiranen T; Palosaari T; Havulinna AS; Fouodo CJK; Scheinhardt MO; Blankenberg S; Jousilahti P; Kuulasmaa K; Zeller T; Salomaa V; Schnabel RB
Europace; 2020 Oct; 22(10):1463-1469. PubMed ID: 32830215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
